CANTATA: Randomized, international, double-blind study of CB-839 plus cabozantinib versus cabozantinib plus placebo in patients with metastatic renal cell carcinoma Meeting Abstract
| Authors: | Tannir, N. M.; Agarwal, N.; Dawson, N. A.; Motzer, R. J.; Jacobs, C. M.; Choueiri, T. K.; Hrom, J. S.; Geynisman, D. M.; Davis, N. B.; Figlin, R. A.; O'Keeffe, M. K.; Parikh, J. R.; Vaena, D. A.; Liu, P. Y.; O'Keeffe, B.; Tran, X.; Escudier, B. |
| Abstract Title: | CANTATA: Randomized, international, double-blind study of CB-839 plus cabozantinib versus cabozantinib plus placebo in patients with metastatic renal cell carcinoma |
| Meeting Title: | 2019 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2019 Feb 14-16 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-01 |
| Language: | English |
| ACCESSION: | WOS:000489108800045 |
| DOI: | 10.1200/JCO.2019.37.7_suppl.TPS682 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS682 -- Source: Wos |
